Table 3

Incidence of CHF in patients receiving imatinib compared with the Framingham heart study

CHF in patients receiving imatinib
Framingham heart study15 
Age group, yNo.New-onset CHF, No. (%)Age, y5-year risk of CHF, %
MenWomen
Younger than 45 409 0 (0) 40 0.2 0.1 
45-55 322 1 (0.3) 50 0.8 0.1 
56-65 291 5 (1.7) 60 1.3 0.7 
66-75 211 6 (2.8) 70 2.2 
76-85 43 4 (9.3) 80 8.3 7.8 
CHF in patients receiving imatinib
Framingham heart study15 
Age group, yNo.New-onset CHF, No. (%)Age, y5-year risk of CHF, %
MenWomen
Younger than 45 409 0 (0) 40 0.2 0.1 
45-55 322 1 (0.3) 50 0.8 0.1 
56-65 291 5 (1.7) 60 1.3 0.7 
66-75 211 6 (2.8) 70 2.2 
76-85 43 4 (9.3) 80 8.3 7.8 
Close Modal

or Create an Account

Close Modal
Close Modal